242 related articles for article (PubMed ID: 7541925)
1. [Status of PSA determination for early detection of prostate carcinoma].
Hammerer P; Huland H
Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
[TBL] [Abstract][Full Text] [Related]
2. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
[TBL] [Abstract][Full Text] [Related]
4. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.
Bare R; Hart L; McCullough DL
Urology; 1994 Feb; 43(2):191-6. PubMed ID: 7509526
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.
Kane RA; Littrup PJ; Babaian R; Drago JR; Lee F; Chesley A; Murphy GP; Mettlin C
Cancer; 1992 Mar; 69(5):1201-7. PubMed ID: 1371234
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen density: a means to enhance detection of prostate cancer.
Ramon J; Boccon-Gibod L; Billebaud T; Astier L; Kobelinsky M; Meulemans A; Dauge MC; Boccon-Gibod L; Villers A
Eur Urol; 1994; 25(4):288-94; discussion 304. PubMed ID: 7519990
[TBL] [Abstract][Full Text] [Related]
7. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
Catalona WJ; Smith DS; Ratliff TL; Dodds KM; Coplen DE; Yuan JJ; Petros JA; Andriole GL
N Engl J Med; 1991 Apr; 324(17):1156-61. PubMed ID: 1707140
[TBL] [Abstract][Full Text] [Related]
8. [Endosonography of the prostate].
Hammerer P
Urologe A; 1991 Nov; 30(6):370-7. PubMed ID: 1722920
[TBL] [Abstract][Full Text] [Related]
9. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer.
Sershon PD; Barry MJ; Oesterling JE
Eur Urol; 1994; 25(4):281-7. PubMed ID: 7519989
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of prostate specific antigen for early stage prostate cancer detection.
Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J; Saitoh M; Watanabe H; Ohe H
Jpn J Clin Oncol; 1994 Jun; 24(3):160-5. PubMed ID: 7516445
[TBL] [Abstract][Full Text] [Related]
11. Impact of prostate-specific antigen density in benign prostatic hyperplasia and prostate carcinoma. Preliminary results.
Akdaş A; Dillioğlugil O; Cevik I; Ilker Y
Eur Urol; 1994; 25(4):299-303; discussion 304. PubMed ID: 7519992
[TBL] [Abstract][Full Text] [Related]
12. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.
Shinohara K; Wolf JS; Narayan P; Carroll PR
J Urol; 1994 Jul; 152(1):120-3. PubMed ID: 7515447
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostate cancer in males with prostatism.
Lepor H; Owens RS; Rogenes V; Kuhn E
Prostate; 1994 Sep; 25(3):132-40. PubMed ID: 7520577
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of benign prostatic hyperplasia and prostate cancer employing prostatic-specific antigen density.
Wolff JM; Scholz A; Boeckmann W; Jakse G
Eur Urol; 1994; 25(4):295-8; discussion 304. PubMed ID: 7519991
[TBL] [Abstract][Full Text] [Related]
15. [The diagnosis of prostatic carcinoma].
Hammerer P; Huland H
Fortschr Med; 1991 Sep; 109(26):512-7. PubMed ID: 1723711
[TBL] [Abstract][Full Text] [Related]
16. Screening for prostatic carcinoma with prostate specific antigen.
Brawer MK; Chetner MP; Beatie J; Buchner DM; Vessella RL; Lange PH
J Urol; 1992 Mar; 147(3 Pt 2):841-5. PubMed ID: 1371559
[TBL] [Abstract][Full Text] [Related]
17. Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer.
Lee F; Littrup PJ; Loft-Christensen L; Kelly BS; McHugh TA; Siders DB; Mitchell AE; Newby JE
Cancer; 1992 Jul; 70(1 Suppl):211-20. PubMed ID: 1376190
[TBL] [Abstract][Full Text] [Related]
18. Digital rectal examination versus transrectal ultrasound in detection of prostate cancer. Preliminary results from a study of a randomly selected population.
Norming U; Gustafsson O; Nyman CR; Almgård LE; Fredriksson A; Gustafsson G; Harvig B
Acta Oncol; 1991; 30(2):277-9. PubMed ID: 1709357
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Wirth MP; Frohmüller HG
Eur Urol; 1992; 21(4):263-8. PubMed ID: 1281102
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen density in patients with histologically proven prostate carcinoma.
Nishiya M; Miller GJ; Lookner DH; Crawford ED
Cancer; 1994 Dec; 74(11):3002-9. PubMed ID: 7525041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
